Rubric Capital Management LP

Holdings History for COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL)

Symbol: COLL on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 3,000,000 shares
Security Ownership %: 9.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Rubric Capital Management LP ownership in COLLEGIUM PHARMACEUTICAL, INC Common Stock, par value $0.001 per share (COLL)

14 May 2025 - Rubric Capital Management LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,000,000 shares of COLLEGIUM PHARMACEUTICAL, INC Common Stock, par value $0.001 per share (COLL). This represents 9.3% ownership of the company. In their previous filing dated 13 Feb 2025, Rubric Capital Management LP had reported owning 2,350,000 shares, indicating an increase of +28%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Rubric Capital Management LP	9.3%	+29%	$78,900,000	3,000,000	+650,000	+28%	$26.30	13G/A	31 Mar 2025	14 May 2025, 16:04
Rubric Capital Management LP	7.3%		$61,805,000	2,350,000			$26.30	13G	31 Dec 2024	13 Feb 2025, 16:01

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	1.3%	-0.16%	$98,899,165	2,826,498	-331,245	-10%	$34.99	Q3 2025
30 Jun 2025	1.5%	+0.08%	$93,374,461	3,157,743	+157,743	+5.3%	$29.57	Q2 2025
31 Mar 2025	1.6%	+0.35%	$89,550,000	3,000,000	+650,000		$29.85	Q1 2025
31 Dec 2024	1.2%	+0.57%	$67,327,500	2,350,000	+1,100,000	+88%	$28.65	Q4 2024
30 Sep 2024	0.79%	-0.69%	$48,300,000	1,250,000	-1,083,500	-46%	$38.64	Q3 2024
30 Jun 2024	2%	0%	$75,138,700	2,333,500	0		$32.20	Q2 2024
31 Mar 2024	2.1%	0%	$71,196,928	1,834,027	0		$38.82^*	Q1 2024
31 Dec 2023	1.8%	-0.49%	$84,899,027	2,758,253	-416,747	-13%	$30.78	Q4 2023
30 Sep 2023	2.7%	-0.21%	$70,961,250	3,175,000	-250,000	-7.3%	$22.35	Q3 2023
30 Jun 2023	3.1%	+0.14%	$73,603,250	3,425,000	+150,832	+4.6%	$21.49	Q2 2023
31 Mar 2023	2%	-0.04%	$78,547,290	3,274,168	-59,460	-1.8%	$23.99	Q1 2023
31 Dec 2022	3.4%	0%	$77,340,170	3,333,628	0		$23.20	Q4 2022
30 Sep 2022	2.7%	+0.06%	$53,405,000	3,333,628	+75,000	+2.3%	$16.02	Q3 2022
30 Jun 2022	3%	+0.24%	$57,743,000	3,258,628	+258,628	+8.6%	$17.72	Q2 2022
31 Mar 2022	2.2%	+0.29%	$61,080,000	3,000,000	+393,500	+15%	$20.36	Q1 2022
31 Dec 2021	2.3%	0%	$48,689,000	2,606,500	0		$18.68	Q4 2021
30 Sep 2021	3%	+0.23%	$51,452,000	2,606,500	+186,286	+7.7%	$19.74	Q3 2021
30 Jun 2021	3.6%	0%	$57,214,000	2,420,214	0		$23.64	Q2 2021
31 Mar 2021	3.4%	+0.86%	$57,359,000	2,420,214	+493,931	+26%	$23.70	Q1 2021
31 Dec 2020	2.8%	0%	$38,583,000	1,926,283	0		$20.03	Q4 2020
30 Sep 2020	3.7%	0%	$40,105,000	1,926,283	0		$20.82	Q3 2020
30 Jun 2020	3.9%	+1.4%	$33,710,000	1,926,283	+712,871	+59%	$17.50	Q2 2020
31 Mar 2020	3.1%	+3.1%	$19,815,000	1,213,412	+1,213,412	NEW	$16.33	Q1 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.